Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ST13P12 is a human pseudogene corresponding to suppression of tumorigenicity 13 (ST13/Hsp70 interacting protein), classified as a non-coding gene with no known protein product or established biological or disease role. Pseudogenes such as ST13P12 are typically genomic sequences similar to functional genes but rendered nonfunctional by mutations, deletions, or frame shifts, and are classified as "processed" or "unprocessed" based on their origin[7][3][4][6]. While some pseudogenes in general can exert regulatory roles through RNA-mediated interactions, there are currently no published data describing a function, disease association, or drug interactions specifically for ST13P12. If you require information about the functional parent gene (ST13), that gene is associated with protein folding, chaperone assembly, and potential roles in tumor suppression, but ST13P12 itself lacks these properties[5][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) pseudogene 12 (ST13P12).